2187 related articles for article (PubMed ID: 12110890)
21. High-mobility group box 1 protein induces HIV-1 expression from persistently infected cells.
Thierry S; Gozlan J; Jaulmes A; Boniface R; Nasreddine N; Strauss F; Maréchal V
AIDS; 2007 Jan; 21(3):283-92. PubMed ID: 17255735
[TBL] [Abstract][Full Text] [Related]
22. High mobility group protein B1 enhances DNA repair and chromatin modification after DNA damage.
Lange SS; Mitchell DL; Vasquez KM
Proc Natl Acad Sci U S A; 2008 Jul; 105(30):10320-5. PubMed ID: 18650382
[TBL] [Abstract][Full Text] [Related]
23. Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis.
Aslani F; Schuppe HC; Guazzone VA; Bhushan S; Wahle E; Lochnit G; Lustig L; Meinhardt A; Fijak M
Hum Reprod; 2015 Feb; 30(2):417-31. PubMed ID: 25452436
[TBL] [Abstract][Full Text] [Related]
24. Potential role of high mobility group box 1 in viral infectious diseases.
Wang H; Ward MF; Fan XG; Sama AE; Li W
Viral Immunol; 2006; 19(1):3-9. PubMed ID: 16553546
[TBL] [Abstract][Full Text] [Related]
25. Binding of histone H1 to DNA is differentially modulated by redox state of HMGB1.
Polanská E; Pospíšilová Š; Štros M
PLoS One; 2014; 9(2):e89070. PubMed ID: 24551219
[TBL] [Abstract][Full Text] [Related]
26. Trimebutine attenuates high mobility group box 1-receptor for advanced glycation end-products inflammatory signaling pathways.
Nakajima S; Ogawa N; Yokoue N; Tachibana H; Tamada K; Okazawa M; Sato A; Oyama T; Abe H; Kamiya T; Yoshimori A; Yoshizawa K; Inoue S; Yokomizo T; Uchiumi F; Abe T; Tanuma SI
Biochem Biophys Res Commun; 2020 Dec; 533(4):1155-1161. PubMed ID: 33041002
[TBL] [Abstract][Full Text] [Related]
27. High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo.
Faraco G; Fossati S; Bianchi ME; Patrone M; Pedrazzi M; Sparatore B; Moroni F; Chiarugi A
J Neurochem; 2007 Oct; 103(2):590-603. PubMed ID: 17666052
[TBL] [Abstract][Full Text] [Related]
28. HMGB1: An overview of its roles in the pathogenesis of liver disease.
Ni YA; Chen H; Nie H; Zheng B; Gong Q
J Leukoc Biol; 2021 Nov; 110(5):987-998. PubMed ID: 33784425
[TBL] [Abstract][Full Text] [Related]
29. HMGB1 is a promising therapeutic target for asthma.
Zhao Y; Li R
Cytokine; 2023 May; 165():156171. PubMed ID: 36924610
[TBL] [Abstract][Full Text] [Related]
30. Dealing with death: HMGB1 as a novel target for cancer therapy.
Lotze MT; DeMarco RA
Curr Opin Investig Drugs; 2003 Dec; 4(12):1405-9. PubMed ID: 14763124
[TBL] [Abstract][Full Text] [Related]
31. HMGB1 as a mediator of necrosis-induced inflammation and a therapeutic target in arthritis.
Andersson U; Tracey KJ
Rheum Dis Clin North Am; 2004 Aug; 30(3):627-37, xi. PubMed ID: 15261345
[TBL] [Abstract][Full Text] [Related]
32. The self-association of HMGB1 and its possible role in the binding to DNA and cell membrane receptors.
Anggayasti WL; Mancera RL; Bottomley S; Helmerhorst E
FEBS Lett; 2017 Jan; 591(2):282-294. PubMed ID: 28027393
[TBL] [Abstract][Full Text] [Related]
33. C-reactive protein induces high-mobility group box-1 protein release through activation of p38MAPK in macrophage RAW264.7 cells.
Kawahara K; Biswas KK; Unoshima M; Ito T; Kikuchi K; Morimoto Y; Iwata M; Tancharoen S; Oyama Y; Takenouchi K; Nawa Y; Arimura N; Jie MX; Shrestha B; Miura N; Shimizu T; Mera K; Arimura S; Taniguchi N; Iwasaka H; Takao S; Hashiguchi T; Maruyama I
Cardiovasc Pathol; 2008; 17(3):129-38. PubMed ID: 18402807
[TBL] [Abstract][Full Text] [Related]
34. HMGB1 as a DNA-binding cytokine.
Andersson U; Erlandsson-Harris H; Yang H; Tracey KJ
J Leukoc Biol; 2002 Dec; 72(6):1084-91. PubMed ID: 12488489
[TBL] [Abstract][Full Text] [Related]
35. HMGB1/Advanced Glycation End Products (RAGE) does not aggravate inflammation but promote endogenous neural stem cells differentiation in spinal cord injury.
Wang H; Mei X; Cao Y; Liu C; Zhao Z; Guo Z; Bi Y; Shen Z; Yuan Y; Guo Y; Song C; Bai L; Wang Y; Yu D
Sci Rep; 2017 Sep; 7(1):10332. PubMed ID: 28871209
[TBL] [Abstract][Full Text] [Related]
36. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation.
Ullah MA; Loh Z; Gan WJ; Zhang V; Yang H; Li JH; Yamamoto Y; Schmidt AM; Armour CL; Hughes JM; Phipps S; Sukkar MB
J Allergy Clin Immunol; 2014 Aug; 134(2):440-50. PubMed ID: 24506934
[TBL] [Abstract][Full Text] [Related]
37. HMGB1 release in co-cultures of porcine endothelial and human T cells.
Kawahara K; Setoyama K; Kikuchi K; Biswas KK; Kamimura R; Iwata M; Ito T; Morimoto Y; Hashiguchi T; Takao S; Maruyama I
Xenotransplantation; 2007 Nov; 14(6):636-41. PubMed ID: 17991152
[TBL] [Abstract][Full Text] [Related]
38. Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review.
Nguyen AH; Detty SQ; Agrawal DK
Anticancer Res; 2017 Jan; 37(1):1-7. PubMed ID: 28011467
[TBL] [Abstract][Full Text] [Related]
39. Quercetin protects necrotic insult and promotes apoptosis by attenuating the expression of RAGE and its ligand HMGB1 in human breast adenocarcinoma cells.
Dhumale SS; Waghela BN; Pathak C
IUBMB Life; 2015 May; 67(5):361-73. PubMed ID: 25983116
[TBL] [Abstract][Full Text] [Related]
40. HMGB1 mediates HAdV-7 infection-induced pulmonary inflammation in mice.
Tang Z; Zang N; Fu Y; Ye Z; Chen S; Mo S; Ren L; Liu E
Biochem Biophys Res Commun; 2018 Jun; 501(1):1-8. PubMed ID: 29571731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
